Literature DB >> 19728129

The effects of intravenous ciprofloxacin on the electrocardiogram of healthy dogs.

Masoud Selk Ghaffari1, Reza Parsamehr.   

Abstract

The purpose of this study was to evaluate the electrocardiographic effects of single intravenous dose of ciprofloxacin in dogs. Ten adult cross-breed dogs of both sexes were selected as the sample population. Baseline electrocardiographic values were recorded just before drug administration. Then the dogs received intravenous infusion of ciprofloxacin (10 mg/kg) over the fifteen minutes. The ECGs recorded at 15, 30, 60 and 120 minutes after ciprofloxacin administration. The ECG measurements of heart rate, PR interval, QRS interval, ST segment, T-wave amplitude and QT interval were taken from lead II. There was a small but significant increase in the longest QT intervals over baseline at T₆₀ (P = 0.041). The mean PR intervals, QTc intervals, JT intervals, ST segment, T-wave amplitude did not differ significantly before and after ciprofloxacin except for JT intervals at T₆₀ (P = 0.041). At this measurement point, there was an increased QT interval value of 0.02 second or 9.51% in comparison to the baseline. In Conclusions, Only minor QT intervals changes were observed after ciprofloxacin injection. Despite the occurrence of ECG changes following intravenous ciprofloxacin administration neither dangerous rhythm disturbances nor serious ECG changes were seen in this study.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19728129     DOI: 10.1007/s11259-009-9317-1

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  8 in total

1.  Effect of autonomic nervous function on QT interval in dogs.

Authors:  Takuma Harada; Junko Abe; Motohiro Shiotani; Yoshimasa Hamada; Ikuo Horii
Journal:  J Toxicol Sci       Date:  2005-08       Impact factor: 2.196

2.  Drug-induced QT interval prolongation after ciprofloxacin administration in a patient receiving olanzapine.

Authors:  Konstantinos P Letsas; Antonios Sideris; Stavros P Kounas; Michalis Efremidis; Panagiotis Korantzopoulos; Fotios Kardaras
Journal:  Int J Cardiol       Date:  2005-06-01       Impact factor: 4.164

3.  Torsades de pointes associated with fluoroquinolones.

Authors:  Robert C Owens; Paul G Ambrose
Journal:  Pharmacotherapy       Date:  2002-05       Impact factor: 4.705

4.  Ciprofloxacin-induced torsade de pointes.

Authors:  M Casey Flanagan; Eric S Mitchell; Mark C P Haigney
Journal:  Int J Cardiol       Date:  2005-12-28       Impact factor: 4.164

5.  Investigation of QT-interval dispersion in the electrocardiogram of 81 dogs.

Authors:  S G Dennis; N J Summerfield; A Boswood
Journal:  Vet Rec       Date:  2002-07-20       Impact factor: 2.695

6.  QT Interval prolongation and torsades de pointes due to a coadministration of ciprofloxacin and azimilide in a patient with implantable cardioverter-defibrillator.

Authors:  Jarosław Kaźmierczak; Małgorzata Peregud-Pogorzelska; Ryszard Rzeuski
Journal:  Pacing Clin Electrophysiol       Date:  2007-08       Impact factor: 1.976

7.  Effects of three fluoroquinolones on QT analysis after standard treatment courses.

Authors:  James P Tsikouris; Michael J Peeters; Craig D Cox; Gary E Meyerrose; Charles F Seifert
Journal:  Ann Noninvasive Electrocardiol       Date:  2006-01       Impact factor: 1.468

8.  Moxifloxacin-induced torsades de pointes.

Authors:  Saadia Sherazi; Michael DiSalle; James P Daubert; Abrar H Shah
Journal:  Cardiol J       Date:  2008       Impact factor: 2.737

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.